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Abstract: Background: Bifidobacterium represents an important early life microbiota member. Specific
bifidobacterial components, exopolysaccharides (EPS), positively modulate host responses, with
purified EPS also suggested to impact microbe–microbe interactions by acting as a nutrient substrate.
Thus, we determined the longitudinal effects of bifidobacterial EPS on microbial communities and
metabolite profiles using an infant model colon system. Methods: Differential gene expression
and growth characteristics were determined for each strain; Bifidobacterium breve UCC2003 and
corresponding isogenic EPS-deletion mutant (B. breve UCC2003del). Model colon vessels were
inoculated with B. breve and microbiome dynamics monitored using 16S rRNA sequencing and
metabolomics (NMR). Results: Transcriptomics of EPS mutant vs. B. breve UCC2003 highlighted
discrete differential gene expression (e.g., eps biosynthetic cluster), though overall growth dynamics
between strains were unaffected. The EPS-positive vessel had significant shifts in microbiome and
metabolite profiles until study end (405 h); with increases of Tyzzerella and Faecalibacterium, and
short-chain fatty acids, with further correlations between taxa and metabolites which were not
observed within the EPS-negative vessel. Conclusions: These data indicate that B. breve UCC2003 EPS
is potentially metabolized by infant microbiota members, leading to differential microbial metabolism
and altered metabolite by-products. Overall, these findings may allow development of EPS-specific
strategies to promote infant health.
Keywords: Bifidobacterium; exopolysaccharides; early life; diet; model colon; cross-feeding; 16S rRNA
profiling; metabolomics
1. Introduction
Members from the genus Bifidobacterium represent one of the dominant bacterial groups in the
early life gut microbiota, with high levels associated with improved infant health [1–5]. Unlike the
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adult gut microbiome, the infant microbiome is less stable, and dietary change is proposed to lead to
severe shifts in the abundance of major bacterial taxa over time [3,6,7]. The gut microbiota of breast-fed
infants is dominated by Bifidobacterium (approx. 80% of the total community), which represents an
important microbial pioneer or founder genus [8,9]. In contrast, formula-fed infants have a more
diverse microbiota and Bifidobacterium comprise a smaller proportion (approx. 5%–30%) [10]. The
introduction of solid food at weaning marks a transition into a more complex microbiome, with a
concurrent reduction in Bifidobacterium levels, likely due to the loss of milk as a sole dietary source.
Notably, during these phases of significant dietary change, there is a shift in bifidobacterial species
and strains, which may link to the wider repertoire of enzymes capable of digesting a more ‘adult’
diet [2,4,6,11].
Currently, only a small number of studies have explored the mechanisms by which Bifidobacterium
species modulate the wider microbiota and/or provide benefits to the host. Several groups have
provided data indicating that many Bifidobacterium species and strains produce exopolysaccharides
(EPSs), which appear to have a variety of roles in microbe–host and microbe–microbe interactions [12].
Bacterial EPS are polymerized mono- or oligo-saccharides which form a diverse range of homo- or
hetero-polysaccharides, that can be linked to the bacterial cell wall or secreted. Analyses of several
Bifidobacterium species has revealed the presence of EPS gene clusters [13], with chemical analysis
indicating glucose and galactose as major components, with very low levels of rhamnose also present
throughout these structures [14,15]. To date, most studies have focused on EPS-host interactions
including: adhesion to host cells, and modulation of epithelial and immune responses [16–18].
Microbe–microbe interactions are a key feature of community structuring and are often mediated
through cross-feeding of microbial-derived metabolites [19]. Interestingly, bifidobacterial EPS has
previously been reported to act as a nutrient source for other bacteria within microbial communities.
In two independent studies, Salazar and colleagues found that isolated EPS from human-associated
Bifidobacterium species may act as a fermentable substrate for other members of the microbiota in faecal
batch cultures (which was species and strain dependent) [20,21]. More recently, this inter-microbial
cross-feeding was also shown in vitro, with EPS from Bifidobacterium animalis subsp. lactis and
Bifidobacterium longum promoting growth of Bacteroides fragilis, which correlated with increased
short-chain fatty acid (SCFA) production [22].
Collectively, these studies suggest a potential role for EPS in microbe–microbe interactions,
by acting as a substrate within gut microbiota cross-feeding networks. However, the exact role of
bifidobacterial EPS in community restructuring is currently unclear as previous studies supplemented
vessels with purified EPS, rather than administrating an EPS-producing Bifidobacterium strain (which
would mimic the actual gut environment). Here, we explored the effects of B. breve UCC2003
(EPS-positive) and B. breve UCC2003del (EPS-negative) on the microbiota using an infant model
colon system. We established differential gene expression and growth characteristics in vitro of each
strain, prior to supplementation, and then performed longitudinal microbiota (via 16S rRNA) and
metabolomic (via NMR) profiling, which indicated that EPS produced by B. breve UCC2003 may
function as a potential dietary substrate that induces remodelling of the early life microbiota.
2. Materials and Methods
2.1. Bacterial Strains and Growth Conditions
The B. breve UCC2003 strains used in this experiment included B. breve UCC2003 (i.e. EPS-positive,
and isolated from infant stool), and EPS deletion mutant B. breve UCC2003del (i.e. EPS-negative, [16]).
All strains were cultured in reinforced Clostridium medium (RCM) and deMan-Rogosa-Sharpe (MRS)
medium and supplemented with 0.05 mg/mL L-cysteine (L-cys) HCl anaerobically at 37 ◦C for upwards
of 48 h. When measuring growth kinetics samples were taken every 2 hours from 0 h to 12 h and 24 h
to 30 h, with a measurement after 48 h of growth. Optical density (600 nm; OD600) and pH values were
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recorded at each time point. For colony forming units (CFU) per mL determination, samples were
plated onto RCM agar plates containing 0.05 mg/mL L-cys-HCl and grown anaerobically for 48 h.
2.2. B. breve Transcriptomics and Bioinformatics Analysis
To identify potential EPS modulated genes, pre-cultures grown in MRS media overnight (as above)
were used to inoculate fresh cultures and cells were harvested at the exponential (approx. 8 h) phase,
PBS washed, and RNA extraction was performed immediately. The cells were resuspended in 600 µL
RLT lysis buffer containing 8 µLβ-mercaptoethanol. The suspension was transferred to Fastprep Lysing
Matrix E tube (MP Biomedicals) and was homogenized using FastPrep-24 instrument (MP Biomedicals,
Irvine, CA, USA) at 6.0 m/s for 3 × 1 min with 5 min resting intervals on ice. Samples were centrifuged
at 14,000 × g for 10 min and RNA was extracted using Qiagen RNeasy mini plus kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions. The RNA quality and concentration were
determined using Agilent 2100 Bioanalyzer (Agilent Inc. Santa Clara, CA, USA). Only samples with
RIN values above eight were sequenced. Isolated RNA was processed with Ribo-depletion, and
samples sequenced on HiSeq V4 75bp (Illumina, Cambridge, UK) using non-stranded, paired end reads.
For computational analysis, the quality of stranded reads was assessed by FastQC software
(version 0.11.8) [23]. Reads were aligned against the full nucleotide sequence of B. breve UCC2003
(RefSeq: NC_020517). The alignment and quantification was performed using Kallisto (version 0.44.0),
the quantified read data was normalized and differential expression analysis was conducted using
DeSeq2 (version 1.22.2) [24,25]. Genes with an absolute log2 fold change ≥1 and p adj value ≤ 0.05 were
considered to be differentially expressed. PCA plots, heatplots and plots of differential expression across
the genome were generated using custom R scripts. All genes in the B. breve UCC2003 genome (RefSeq:
NC_020517) were functionally annotated with categories and descriptions using EggNog-mapper
(version 4.5) [23]. Custom R scripts were used to test for enrichment of EggNog functional categories
in the upregulated and downregulated differentially expressed genes. This analysis was carried out
using gene set enrichment functions of the R package clusterProfiler (version 3.10.1) [26]. All raw reads
were deposited in European Nucleotide Archive: PRJEB35291.
2.3. Transmission Electron Microscopy (TEM)
Strains were grown as described above, and after 48 h growth, cells were centrifuged at 4500 × g
at 4 ◦C for 10min with low break. Bacterial pellets were resuspended in 1mL of fixative comprising
2.5% glutaraldehyde in 0.05 M sodium cacodylate pH 7.2. Fixation was carried out for 1.5 h at room
temperature, after which cell suspensions were centrifuged (7.5 xg rpm, 3 min) and washed in 0.05 M
Sodium Cacodylate buffer ×3 (10 min). After final centrifugation, cell pellets were mixed 1:1 with
molten 2% low gelling temperature agarose, solidified by chilling, and then chopped into 1mm3 pieces.
Sample pieces were post fixed in 1% OsO4 for 2 h followed by washing ×3 (15 min) in deionized water.
Sample pieces were then dehydrated through an ethanol series (30%, 50%, 70%, 90%, 100% ×3) for at
least 15 min in each ethanol dilution. Samples were infiltrated with a 1:1 mix of LR White medium
grade resin to 100% ethanol, followed by a 2:1 and a 3:1 mix and finally 100% resin, with one hour
between each change. This was followed by two more changes into fresh 100% resin, with periods
of eight hours between. Four blocks/sample were put into Beem capsules (Size 00, EMS, Hatfield,
PA, USA) with fresh resin and polymerized for 24 h at 60 ◦C. Sections approximately 90 nm thick
were cut using an ultramicrotome with a glass knife, collected on formvar/carbon coated 200 mesh
copper grids, stained sequentially with 2% uranyl acetate for 1 h at room temperature, and added
to 0.5% lead citrate-tribasic trihydrate for 1min at room temperature. Deionised water washes were
performed (×5) following each of the staining steps. Sections were examined and imaged in a Talos
F200C transmission electron microscope (Thermo Fisher, Waltham, MA, USA) at 200 kV with a “Gatan
One View” digital Camera.
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2.4. Infant Model Colon System
All subjects gave their informed consent for inclusion before they participated in the study. The
study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by
the Quadram Institute Bioscience Ethics Committee and in accordance with protocols by the National
Research Ethics Service (NRES) approved UEA/QIB Biorepository (Licence no: 11208). Faeces were
collected from healthy, full-term breast-fed infants (aged from seven months to one year old). One-gram
samples from five frozen stool samples were homogenized with 5mL reduced PBS (500 µL of 3% L-cys
HCl in 50mL PBS), filtered (70 µm) and evenly distributed to each vessel. Samples were pooled based
on previous work indicating combined samples robustly demonstrated a median value of the donors
and provided a more stable environment for downstream microbiome and metabolite analysis [27].
Model colon system media was made according to Cinquin et al., and included a vitamin solution
(pantothenate 10 mg/L, nicotinamide 5 mg/L, thiamine 4 mg/L, biotin 2 mg/L, vitamin B12 0.5 mg/L,
menadione, 1 mg/L and p-aminobenzoic acid 5 mg/L) as described in Gibson and Wang [28,29].
The continuous-fed batch cultivation was performed in 1.4 L bioreactors (Multifors) and monitored
with Eve®software (Infors AG, Basel, Switzerland). Parameters were set according to [28]; briefly,
vessels were maintained at 37 ◦C, pH 6.7 and anaerobic, with a media exchange occurring every 12 h
(retention time). All vessels were given 10 days to permit equilibrium of the microbiota to the in vitro
vessel environment.
For inoculation of B. breve, strains were grown in the infant gut media. Overnight cultures were
then centrifuged at 4500 × g for 10 min at 4 ◦C, washed with PBS and then inoculated into each vessel.
B. breve UCC2003 EPS-positive 4.4 × 108 CFU/vessel, and B. breve UCC2003del EPS-negative 2.4 × 108
CFU/vessel was added. Samples were snap frozen in liquid nitrogen at each time point t = 0, 6, 12, 24,
36 hours post inoculation with B. breve, and once a day from that time point onward.
2.5. DNA Extraction, 16S rRNA Library Preparation, Sequencing, and Bioinformatics Analysis
For genomic DNA extraction of the samples FastDNA®Spin Kit for Soil (MP Biomedicals, Irvine,
CA, USA) was used according to the manufacturer’s instructions with an additional two bead-beating
runs of 60 s and setting 6.0 m/s. DNA quantification was determined with the Qubit®2.0 Fluorometer
(Thermo Fisher, Waltham, MA, USA) using the broad range Qubit®Assay Kits for DNA, RNA and
Protein following manual instructions, and DNA was normalized to a final concentration between
4–20 ng/µL prior to 16S PCR analysis.
V1 and V2 of the 16S rRNA gene were targeted and amplified using a Q5 high-fidelity polymerase
kit. Primer sequences for amplification are found in Table S1. PCR amplification conditions were:
1 cycle of 98 ◦C for 2 min, followed by 20 cycles of 98 ◦C for 30 s, 50 ◦C for 30 s and 72 ◦C for 90 s, and
a final cycle of 72 ◦C for 5 min. PCR products were purified using Ampure XP beads (Agencourt,
Beckman Coulter, Brea, CA, USA) and pooled in an equivalent molar mix based on the concentration of
each PCR product determined by Quant-iT™ PicoGreen®dsDNA Assay Kit (Thermo Fisher, Waltham,
MA, USA ). Sequencing was performed on an Illumina MiSeq platform using paired end reads (average
read length was 330 bp). 16S rRNA gene sequencing analyses and bioinformatics analyses were
performed as previously published [30]. All raw reads were deposited in the European Nucleotide
Archive: PRJEB35291.
2.6. 1H NMR Analyses
For the analysis, 50 mg of model colon samples were mixed with 700 µL NMR buffer (0.26 g
NaH2PO, 1.44 g K2HPO4, 17 mg TSP, 56.1 mg NaN3 and 100 mL D2O) and centrifuged at 14000 × g at
4 ◦C for 5 min. Then, 600 µL of supernatants were transferred into NMR tubes (GPE Scientific Ltd,
Leighton Buzzard, UK) and the 1H NMR spectrum was recorded at 600 MHz on a Bruker Avance
spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany) running Topspin 3.2 software. Each
1H NMR spectrum was acquired with 128 scans, a spectral width of 12300 Hz and an acquisition
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time of 2.7 s. The “noesygppr1d” presaturation sequence was used to suppress the residual water
signal with a low power selective irradiation at the water frequency during the recycle delay (3 s).
Spectra were transformed with a 0.3-Hz line broadening, automatically phased, baseline corrected, and
referenced by setting the TSP methyl signal to 0 ppm. Metabolites were identified and subsequently
quantified using a library of reference standard spectra provided with the Chenomx NMR suite 8.4™
software (Edmonton, AB, Canada).
2.7. Statistical Analyses and Plotting
Statistical analyses on growth curves were performed in GraphPad Prism version 5.04 (San Diego,
CA, USA). Mann-Whitney-U-Test was performed for cultures in MRS. Error bars denote standard
deviation (SD). All plots were produced using either GraphPad Prism version 5.04 or R Studio version
1.1.463 using the ggplot2 R package version 3.1.0. For NMDS (Non-metric multidimensional scaling) in
R Studio, the 16S rRNA bacterial sequence data were subsampled to an even depth of 120,070 sequences
using phyloseq package version 1.24.2. NMDS plots were generated with a Bray–Curtis dissimilarity
calculation in R Studio used with the vegan package version 2.5-4 in R Studio version 1.1463 with
R 3.5.0. The Spearman correlation analysis was calculated using Kendall in R Studio (version 1.1463).
3. Results
3.1. Surface-Associated EPS Influences B. breve Gene Expression
Pure bacterial cultures were subjected to TEM to visualize the presence and absence of EPS prior
to model colon experiments. Images indicated EPS-positive B. breve UCC2003 bacteria had a thicker
and differentially stained cell wall (as indicated by arrows, Figure 1a), in contrast to the EPS-negative
strain (i.e. B. breve UCC2003del) which is in line with previously published data [16].
Previous work has suggested that bacterial EPS may act as a signalling molecule, and
therefore its absence may alter bacterial gene expression [31]. To examine this, we grew B. breve
EPS-positive and B. breve EPS-negative in culture until mid-exponential phase and isolated mRNA for
transcriptome analysis. Principal component analysis (PCA) showed separation between EPS-positive
and EPS-negative conditions (45% of variance, Figure S1a); in addition, we found 51 upregulated and
83 downregulated genes (comparing EPS-positive to EPS-negative with an absolute log2 fold change
≥1 and p adjusted value ≤ 0.05; Figure 1b,c). Annotation of regulated genes indicated high differential
expression around the B. breve EPS cluster (Figure 1d; cluster at position ~600,000). The EPS-related
cluster was the only full gene cluster differently regulated between the two isolates during growth
in rich media, suggesting that these strains are highly similar despite the lack of EPS structure on
the mutant strain. Using the EggNog mapper to functionally classify differentially expressed genes
(from EPS+ vs EPS− cultures), the majority of genes were assigned to unknown function (18 genes
up-regulated in EPS+ and 25 genes upregulated in EPS−, data not shown). In general, we found
that the EPS− strain had a greater number of significant genes upregulated in metabolic pathways
(including carbohydrate, nucleotide, inorganic ion, lipid and amino acid transport/metabolism) and
bacterial cell growth (cell wall/membrane/envelope biogenesis and transcription; Figure 1e). Overall
the EPS+ strain had fewer significantly differentially expressed genes, but in contrast to EPS−, EPS+
bacteria had a higher proportion of gene expression related to replication/recombination and repair,
energy production and post-translation modification/protein turnover/chaperones and coenzyme
transport and metabolism (Figure 1e). Collectively, this data suggests that the absence of EPS alters
gene expression of many metabolic pathways, but importantly it does not influence overall growth
kinetics (Figure S1b).
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Hierarchical clustering of samples. Significance based on adjusted p value. (d) Bar plot of EPS+ vs 
EPS‐ differential gene expression  (absolute  log2  fold change  ≥1 and p adj value  ≤ 0.05) across  the 
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3.2. B. breve EPS Influences Infant Microbiome Composition over Time
To determine if bifidobacterial EPS acts as an additional nutrient substance, impacting cross-feeding
activities, B. breve strains were inoculated into a complex infant model colon system (as depicted in
Figure 2a). We used 16S rRNA gene analysis to probe kinetics of bacterial community changes induced
by the presence of B. breve EPS-positive or EPS-negative strains over 405 hours of culture.
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12 h), B. breve accounted for appr ximately half of the total Bifidobacterium relativ abundance wit in
the EPS-p sitive vessel, and one-third of th total bifidobacterial abundance in the EPS-negative vessel
(Figur S4 ,b). This is perhaps unsurprising, sinc it h s been previously reported that once stability
has been reached in the microbiota, only one-third of individuals are colonized with Bifidobacterium
after supplementation [32]. Despite short-term colonization, overtime microbial diversity in each
vessel shifted as indicated by NMDS plots f total taxonomic profiles (Figure 2b, Figure S3a, ), with
specific changes in microbial com osition and abundancy bser ed in each vessel throughout the
experimental period (Figure 3 and Figure S5, Tables S2 and S3). Comparing the wider bacterial genus,
community profiles of the vessels indicated that both EPS-positive an EPS-negative conditions had
similar core microbiomes; therefore, we chose to focus our analysis on the top five genera in each
condition. All vessels were dominate with a igh proportion of (1) Clostridium, (2) Bacteroides and
(3) Erysipelatoclostridium across all time points (Figure 3a,b). Within the EPS+ vessel Faecalibacterium
was the fourth most abundance genera across most time points; whilst bacteria belonging to the
genera Escherichia were the fifth most prevalent at 0–36 h, from 48–129 h Tyzzerella was fifth, and
Enterococcus from 144–408 h (Figure 3a,c and Table S2). These shift in the top five genera within
vessels corresponded to three unique microbial ‘phases’ (I, II, and III). Notably, the presence of EPS
(i.e. EPS+ vessel) correlated with different ecosystem structuring (Figure 3a,c and Table S2) when
compared to EPS– vessel (Figure 3b,d and Table S3). Earlier time-points (0–36 h) showed similar relative
genus abundances; Clostridium, Bacteroides, Erysipelatoclostridium, and Faecalibacterium, with Escherichia
higher in the EPS– vessel. In the second phase from 48–120 h, Faecalibacterium relative abundance
was decreased in both vessels (although not as significantly in the EPS+ vessel), with proportions of
Clostridioides increased in the EPS− vessel. In phase I and crossing to phase II, we observed an increase
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in Tyzzerella in the EPS+ vessel (from 12 h). In phase II (48–120 h), Lachnoclostridium and Tyzzerella
had increased read counts, whereas Escherichia decreased in the EPS− vessel. In the last phase (III),
at 168 h–312 h, we observed a spike in Faecalibacterium in the EPS+ vessel, followed by a ‘wave’ of
Enterococcus (192–408 h), whereas the number of reads from Tyzzerella decreased towards the end
(Figure 3a, c; purple for Faecalibacterium, green for Enterococcus). The EPS− vessel was observed to have
a steady increase in relative abundance of Faecalibacterium, with overall reductions in Clostridioides
(Figure 3b,d; purple for Faecalibacterium, green for Enterococcus). These profiles indicate distinct and
major changes in bacterial genera in response to B. breve UCC2003-associated EPS.Nutrients 2020, 12, x FOR PEER REVIEW  9 of 18 
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Using Spearman correlation analysis, we next assessed if the presence of total Bifidobacterium
correlated with other bacterial genera (Figure S6). Overall, we noted that most genera were found to be
(weakly) negatively correlated in the EPS+ vs. the EPS– vessel, with a strongly positive co-occurrence of
Bifidobacterium with F ecalibacter um the EPS− vessel (p = 0.033; Figur S6). T determine putative EPS
cross-feeding partners, we also analysed for co-occurrences with B. breve (i.e. specific for EPS+/EPS−
supplemented strains), finding that, although not significant, there was a trend for more positive
correlations with several genera in the EPS+ vessel including Streptococcus and Ruminococcus with
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B. breve. In general, we observed fewer positive correlations between EPS− and B. breve, with the genus
Dorea significantly negatively correlated (Figure S6). Collectively, this might suggest that the presence
of EPS is responsible for driving changes in microbiome profiles, likely due to the fact it can function
as a potential metabolite for other members in the microbiota.
3.3. Metabolite Profiles Shift in Response to Bifidobacterial EPS
Using 1H NMR, we next sought to examine if the taxonomic compositional changes observed
were also linked to overall metabolic changes. In agreement with the microbiota profiles, both vessels
had similar starting metabolite concentrations prior to the introduction of B. breve (Figure S7a). The
most abundant metabolites in each vessel were formate, succinate, ethanol, and bacterial fermentation
by-product SCFAs: acetate, butyrate and propionate (Figure 4a–d; Table S4). Proportions of all SCFAs
increased over time independent of the presence/absence of EPS (Figure 4c,d) [33]. We also observed
that within the EPS− vessel, the concentration of ethanol was similar at the start and end, but with
variations over time, including a peak from 120–168 h, whilst the EPS+ vessel appeared to have
decreased levels. The abundance of the simple organic compound formate increased in abundance
until 120 h within the EPS+ vessel, then dropped in the third phase (144–406 h) but remained stable in
the EPS− vessel. We observed that the sugar compound succinate decreased with time in the EPS−
vessel, whilst levels were relatively unchanged in the EPS+ system. Other notable differences in the
EPS+ vessel included an increase in propionate during phase III (after 168 h). Taken together, these
results further suggest that addition of bacteria with an EPS structure alters bacterial function and
metabolic output.
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Direct comparison of metabolic and microbiota profiles using Spearman correlation analysis
identified changes, across phases and overall, that may be linked to EPS-mediated metabolic changes
(Figure 2a, Figure 5 and Figure S7b,c). Overall, we noted more significant associations in the EPS+
vessel, and therefore chose to focus on the most abundant metabolites with the top ten bacterial
genera across the experimental period (Figure S7b). The strongest positive correlations across the
whole experimental period (i.e. both genus and metabolite increasing; p ≤ 0.001) were observed in the
EPS+ vessel between Bifidobacterium and ethanol; Tyzzerella, Escherichia, Clostridium, Agathobacter and
formate; Enterococcus, Bacteroides and propionate and, Escherichia and succinate (Figure S7b,c; Table
S5). The presence of EPS+ B. breve was positively associated the SCFA butyrate and Clostridioides
(and negatively associated in the EPS− vessel). Additionally, propionate was significantly negatively
correlated with the proportion of Tyzzerella and Agathobacter in the EPS+ vessel and Clostridioides in
the EPS− vessel. We also explored changes occurring during the different phases to more closely
explore direct vs. indirect EPS metabolism associations (Figure 5). When B. breve was present at high
abundance (i.e. Phase I) we noted (weakly) positive associations with Tyzzerella and butyrate in the
EPS+ vessel, but the opposite (negative) associations in the EPS− vessel; a negative association was
also observed for acetate and Bacteroides, and Clostridioides and formate. In phase II, we observed very
similar positive associations in the EPS+ vessel (as in phase I) across genus and metabolites, although
in some cases the associations appeared less strong which may correlate with reductions of EPS as a
cross-feeding substrate (via loss of B. breve). The final phase III analysis indicated overall reductions in
positive associations and metabolites in EPS+ vessel, and a move towards more negative associations
which may be indicative of a complete loss of EPS as a nutrient at these later time-points. We did
observe several new associations: a positive association with Faecalibacterium and butyrate in the
EPS+ vessel, and a significantly strong negative association between Faecalibacterium and propionate,
with the opposite (positive) trend with Enterococcus and propionate. The apparent differences in the
metabolome with bacterial genus correlations indicate distinct and related changes due to the presence
(or absence) of EPS, and may possibly infer active EPS metabolism (when present) by members of the
wider early life microbiota.
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4. Discussion
Previous studies have indicated that bifidobacterial EPS plays a key role in mediating beneficial
microbe–host interactions [1]. Earlier studies have also suggested that EPS potentially acts as a
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dietary component, facilitating cross-feeding within microbial communities [20,21]. EPS molecules are
large surface-bound polymers surrounding the cell wall of many Gram-positive bacteria, including
Bifidobacterium species [12]. Expression of EPS may influence overall growth of B. breve due to
increased energy expenditure, and/or EPS modulation of bacterial gene expression, which may impact
profiles within complex microbial ecosystems [17]. RNASeq analysis indicated regulation of the EPS
biosynthetic gene cluster (including glycosyltransferases), suggesting that EPS may act to modulate its
own production, as indicated by TEM images [16]. Indeed, previous work in Bacillus subtilis indicates
that the presence of EPS promotes the phosphorylation of a glycosyltransferase in the biosynthetic
pathway, thereby stimulating the production of EPS [31]. We found that in vitro, presence of EPS did not
significantly alter overall gene expression or growth, indicating any changes observed from the addition
of B. breve UCC2003 EPS-positive/negative to a complex microbiota are due to presence (or absence) of
EPS, rather than inherent cell response differences due to the additional exopolysaccharide motif.
Significant variations are often observed between infant microbiotas, particularly during weaning
when ecosystems are undergoing rapid change in response to a changing nutritional environment
(between 6–12 months of age). Our 16S rRNA amplicon analyses of the microbial ‘baseline’ model colon
profiles revealed an expected weaning infant core microbiome; namely, dominance of the Bacteroides
genus, and members of the phylum Firmicutes (e.g., Clostridium and Erysipelatoclostridium), with
reduced abundance of Bifidobacterium [2,4,11]. This developmental window represents an important
dietary transition period for infants, moving from milk (breast or formula) to solid food; therefore,
access to additional microbial-derived nutrients, such as EPS, may contribute to driving ecosystem
re-structuring [3]. Indeed, our research indicates that B. breve UCC2003 can modulate the infant
microbial community structure and metabolism, and in line with previous studies we noted alterations
in microbially-derived SCFAs, acetate, propionate and butyrate, although we did not detect the
previously reported EPS driven acetate to propionate ratio change [20,21], which may be due to
experimental and inoculating infant microbiota differences. However, as this is an individual model
colon study the microbiota and the metabolite profiles presented only suggest putative direct and
indirect EPS-associated modulations, careful interpretation of the data presented is required.
Previous studies on B. breve EPS has identified glucose and galactose as main components of EPS,
which is similar to that proposed for UCC2003 EPS structure (includes glucose, galactose and/or the
N-acetylated versions of these two sugars in different ratios or composition) [12,14–16]. The large
molecular weight and structure of these EPSs may prevent host-associated digestion, allowing them to
act as prebiotics within the colon (similar to inulin and fructooligosaccharide) [18,33,34]. From our
analysis, we did not observe major shifts in the dominant microbiota genus during phase I in the EPS+
vessel, although at the mid-point in phase I and into phase II we noted an increase in the infant-gut
associated bacteria Tyzzerella [4]. The timing of this increase suggests this early-life member may be
using EPS as a key nutritional supplement. Although little is known regarding the metabolism of
members the Tyzzerella genus, many other members of the family Lachnospiraceae possess glycoside
hydrolases used for the metabolism and transport of oligosaccharides into the cell [35]. Furthermore,
another member of the Lachnospiraceae family, Ruminococcus, degrades intestinal mucins (similar in
structure to EPS) liberating metabolites for other members of the microbiota to consume [36]. Indeed,
we also noted a positive association between B. breve and Ruminococcus (which was one of the lower
relative abundance microbiota members), also in the EPS+ vessel. Thus, the positive correlation of
Tyzzerella with formate (and butyrate) in the EPS+ vessels suggests that, similar to other members in
the Lachnospiraceae family, Tyzzerella (and Ruminococcus) may be consuming EPS and producing SCFAs
as fermentation end-products [37]. Moreover, we observed several other strong negative correlations
between different genera (e.g., Dorea) and B. breve UCC2003, and E. coli only ‘blooming’ in the EPS−
vessel in phase I, which also suggests antagonistic networks may be EPS-dependent, but further studies
are required to understand the mechanisms promoting these inverse relationships. It should be noted
that we only observed short-term ‘colonization’ of the respective B. breve strains; therefore, the earlier
changes observed may link to direct metabolism, whilst the long-term changes in our model gut system
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(e.g., phase III increases in Faecalibacterium and Enterococcus and concurrent changes in propionate in the
EPS+ vessel) may result from those initial cross-feeding interactions modulating the wider microbiota
over time. Further studies using other Bifidobacterium species and strains with different EPS could
provide further resolution on the importance of EPS acting as a putative dietary substrate in the wider
microbiota over longer time-periods. Moreover, as this was a model colon study, with tight kinetic
sampling, we did not perform multiple replicates (approach in line with other studies [38–40]), which
is a limitation of this study. However, we did allow for stabilization as pre previous group protocols,
and included mixed infant-associated fecal sample as the initial batch to reduce inter-microbiota
variability [27,38,39]; further studies could inoculate individual infant ecosystems and explore the
impact of EPS metabolism and cross-feeding interactions within and between different infants.
As highlighted above, the infant microbiota represents a dynamic ecosystem, with complex feeding
networks at play, which may also be acting in response to EPS metabolism. We noted several potential
wider cross-feeding networks (rather than direct EPS digestion interactions) during different growth
phases. Specifically, utilization of B. breve EPS by proposed primary degraders highlighted from the
genus-metabolites association analysis in phase I, e.g., Bacteroides, producing acetate may also facilitate
the later growth of other microbiota members such as weaning-associated Faecalibacterium, important
butyrate producers, as these metabolites correlate respectively with these genera [38,39]. Another
possible interaction is via predicted production of formate by Tyzzerella, that may be metabolized
by Faecalibacterium, as has been described in an in silico biofilm model [41]. Delineating intricate
and complex cross-feeding relationships is difficult and cannot be predicted from non-community
cultures, as strains grow and behave differently when grown in co-culture compared to those grown
individually [19,42]. However, direct co-culture studies could provide some indications of the ability for
certain microbiota members to directly metabolize EPS, like has been done previously for other dietary
components such as human milk oligosaccharides [8,43]. Further, more in-depth studies, possibly
utilizing isotope labelling, would be required for targeted identification of metabolites impacting these
important EPS-associated cross-feeding networks [44].
The microbiota-associated changes observed after potential EPS metabolism and cross-feeding
interactions may also be expected to impact host responses. Previous studies have shown a key role
for direct EPS host modulation (including for B. breve UCC2003) via signaling through epithelial and
immune cells [12,45]; however, changes in the wider microbiota via dietary interventions are also
known to impact host responses [46]. Further studies using in vivo models, including gnotobiotic mice,
or indeed human supplementation studies could provide insights into additional beneficial impacts of
EPS-host interactions.
5. Conclusions
To our knowledge, this research demonstrates for the first time the influence of B. breve UCC2003
EPS on the infant microbiota using an in vitro model colon system. Although a dynamic system,
with media constantly replenished and waste removed, we observed short-term colonization that
contributed to altered bacterial composition (i.e. abundance of Tyzzerella) and metabolite profiles
(i.e. acetate, propionate, formate or butyrate) within the EPS-positive B. breve UCC2003 inoculated
vessel. These combined data suggest EPS may act as a nutrient source for certain microbiota members,
thereby driving community re-structuring during early life changes, although outputs should be
interpreted carefully due to experimental limitations. Our results, in combination with previously
published work [20,21], suggest that early life supplementation with EPS-positive Bifidobacterium strains
may promote infant well-being by aiding and supporting beneficial infant microbiota development.
Finally, this work, including the identification of microbial associations and metabolites within a
healthy microbiota, could be used as a platform for development strategies of future nutritional and
microbial therapies.
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